Detalhe da pesquisa
1.
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment.
Eur J Haematol
; 105(2): 196-202, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32281193